Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 259 of 6351
-
Brain training may ward off depression in vulnerable teens
Prevention CompletedThe goal of this clinical trial is to learn if intervention of positive emotion working memory (PEWM), or negative emotion working memory (NEWM), or positive attention bias training (PABT) can prevent major depressive disorder (MDD) for the long-term effects of intervention in yo…
Sponsor: Hunan Normal University • Aim: Prevention
Last updated Aug 12, 2026 00:00 UTC
-
Tai chi for the brain: can a mindful exercise program slow memory loss?
Disease control CompletedTo determine the efficacy of a cognitively enhanced exercise intervention - Tai Ji Quan: Moving to Maintain Brain Health in improving global cognitive function and dual-task ability in older adults with mild cognitive impairment.
Sponsor: Oregon Research Institute • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Could less radiation be enough for HPV throat cancer?
Disease control OngoingThis phase II/III trial studies how well a reduced dose of radiation therapy works with nivolumab compared to cisplatin in treating patients with human papillomavirus (HPV)-positive oropharyngeal cancer that is early in its growth and may not have spread to other parts of the bod…
Phase 2/3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Weight-Loss drug semaglutide tested in teens – could it help?
Disease control CompletedThis study will look at the change in teenagers' body weight from the start to the end of the study. This is to compare the effect on body weight in teenagers taking semaglutide (a new medicine) and teenagers taking "dummy" medicine. The teenagers in the study and their parents w…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could an immunotherapy combo replace harsh chemo for head and neck cancer?
Disease control OngoingThe purpose of this study is to investigate other drugs that may be combined with radiation to treat cancer. The study focuses on determining whether a combination of durvalumab with radiation can both improve cure rate and at the same time have less serious side effects. Through…
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Can Ultrasound-Guided biopsies improve breast cancer diagnosis in nigeria?
Diagnosis Recruiting nowThe purpose of this study is to train Nigerian radiologists to perform ultrasound-guided breast biopsies on women that present to the hospital with a suspicious breast mass. Before performing biopsies on patients, the Nigerian radiologists will have already successfully completed…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Aug 29, 2026 00:00 UTC
-
Could botox in the heart stop Post-Surgery AFib?
Disease control OngoingOver the past few years, research has focused on the prevention of atrial fibrillation (AF) after cardiac surgery, but highly effective interventions are still missing. Postoperative AF remains the most common complication after cardiac surgery, with an incidence of 10 to 50%. Th…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a neck implant lift severe depression?
Disease control Recruiting nowObjectives of this study are to determine whether active VNS Therapy treatment is superior to a no stimulation control in producing a reduction in baseline depressive symptom severity, based on multiple depression scale assessment tools at 12 months from randomization.
Sponsor: LivaNova • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug guselkumab shows promise for ulcerative colitis in large trial
Disease control OngoingThe purpose of this study is to evaluate the efficacy and safety of guselkumab in participants with moderately to severely active ulcerative colitis (UC).
Phase 2/3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could a Sleep-Focused therapy ease depression, anxiety, and PTSD?
Symptom relief CompletedCognitive Behavioral Therapy (CBT) is treatment of choice for insomnia. Many patients in psychiatric care have sleep problems including insomnia, but are rarely given the choice to participate in CBT to improve their sleep. Patients with PTSD, Anxiety disorders and Depression dis…
Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Can a blood thinner safely prevent strokes after a brain bleed?
Disease control CompletedTo assess whether edoxaban (60/30 mg daily) compared to non-antithrombotic medical therapy (either no antithrombotic therapy or antiplatelet monotherapy) reduces the risk of stroke (composite of ischemic, hemorrhagic and unspecified stroke) or systemic embolism in high-risk atria…
Phase 4 • Sponsor: Population Health Research Institute • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Could a common antibiotic wake up the sleepy brain?
Disease control CompletedThe purpose of this study is to evaluate a medication called clarithromycin for treating sleepiness in narcolepsy and idiopathic hypersomnia. Studies have shown that clarithromycin can reduce sleepiness, but researchers do not know how clarithromycin does this. This study will lo…
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could a chemo boost after radiation tame aggressive prostate cancer?
Disease control Recruiting nowThis study aims to evaluate the efficacy of adjuvant docetaxel chemotherapy following radical radiotherapy in patients with localized high-grade prostate cancer. Eligible participants include those diagnosed with prostate cancer confirmed by biopsy or surgical pathology, with a G…
Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New hope for bladder cancer patients who failed standard treatment
Disease control Recruiting nowThis is a phase II, open-label, single-arm, multi-center Study conducted in Canada and the United States. Patients with Non-Muscle Invasive Bladder Cancer ("NMIBC") Carcinoma In-Situ ("CIS") (with or without resected papillary disease (Ta, T1)) that are considered Bacillus Calmet…
Phase 2 • Sponsor: Theralase® Technologies Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New chemo combo aims to beat childhood lymphoma relapses
Disease control Recruiting nowPrimary objectives: * Randomization R1, all patients eligible: To examine, whether the cumulative incidence of relapses with involvement of the CNS (CNS relapse, pCICR) can be decreased by a modified induction therapy including dexamethasone (experimental arm) instead of prednis…
Phase 3 • Sponsor: University Hospital Muenster • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for lymphoma patients who Can't have transplants
Disease control OngoingThis is a randomized study to compare the efficacy and safety of zanubrutinib plus rituximab versus bendamustine plus rituximab in previously untreated participants with mantle cell lymphoma (MCL) who are not eligible for stem cell transplantation.
Phase 3 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Can a new drug combo push CML into deep remission?
Disease control OngoingAdult male and female patients with newly diagnosed Philadelphia chromosome positive (Ph+) and/or BCR-ABL1 positive CML can be included in the study until 3 months after diagnosis. A \<4 week pretreatment with hydroxyurea is permitted. Patients treated for \<6 weeks with nilotini…
Phase 2 • Sponsor: University of Jena • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can a Once-Monthly shot tame Acromegaly's hormone overdrive?
Disease control CompletedThe purpose of this trial is to assess the efficacy and safety of CAM2029 in patients with acromegaly. Patients will be randomized to either CAM2029 or placebo administered subcutaneously once monthly during 6 months.
Phase 3 • Sponsor: Camurus AB • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Immunotherapy after standard treatment may keep HPV throat cancer at bay
Disease control OngoingThis phase III trials studies whether maintenance immunotherapy (nivolumab) following definitive treatment with radiation and chemotherapy (cisplatin) result in significant improvement in overall survival (time being alive) and progression-free survival (time being alive without …
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Could a liver transplant from a living donor help fight colorectal cancer that spread?
Disease control Recruiting nowThe goal of this study is to create a data registry to capture clinical, pathologic, and molecular data/outcomes for patients with metastatic colorectal cancer who undergo live donor liver transplantation.
Sponsor: University of Rochester • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC